[Magnetic growth rods for the scoliosis treatment in children]
Comite dĀ“Evaluation et de Diffusion des Innovations Technologiques (CEDIT)
Record ID 32015001197
French
Authors' objectives:
The CEDIT assessed the impact of magnetic growth rods for the scoliosis treatment in children, in order to inform the decision making process of its adoption at the Paris University Hospital (AP-HP). Scoliosis is a sideways permanent curvature of the spine. The severe form, Early Onset Scoliosis (EOS), could require a surgical treatment like the insertion of growth rods. The new technology available is the magnetically controlled growing rods, object of the present assessment report.
Authors' recommendations:
Taking into account the available data, the CEDIT recommends:
Give the possibility to AP-HP to adopt and use the MAGEC system for children aged 2 to 11 years old suffering of Early Onset Scoliosis and requiring this kind of treatment.
Set up or participate in a registry for the initial intervention and the follow-up of children, in order to inform the patients' characteristics and to follow the clinical effectiveness of this health technology.
Take into consideration the possibility to encourage the teams of AP-HP to come closer in order to share, preserve and improve et current and the future clinical expertise in this field
Seek with the practitioners involved and the manufacturer to promote a national assessment of this technology, aiming to propose for reimbursement the device and the associated procedure.
Details
Project Status:
Completed
Year Published:
2015
URL for published report:
http://cedit.aphp.fr/magnetic-growth-rods-scoliosis-treatment-children/
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
MeSH Terms
- Humans
- Child
- Magnetics
- Scoliosis
Contact
Organisation Name:
Cellule Innovation of the AP-HP
Copyright:
Comite dĀ“Evaluation et de Diffusion des Innovations Technologiques (CEDIT)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.